U.S. EPA SITE demonstration of AWD Technologies' AquaDetox/SVE system.

Under the Superfund Innovative Technology Evaluation (SITE) Program, a technology developed by AWD Technologies, Inc. was demonstrated in September 1990. This paper presents the major results of the SITE demonstration of AWD Technologies' AquaDetox/SVE treatment system designed for simultaneous on-site treatment of contaminated groundwater and soil-gas. The groundwater and soil at the demonstration site were contaminated with trichloroethylene (TCE) and tetrachloroethylene (PCE). The AWD technology was evaluated on the basis of the removal efficiencies of TCE and PCE from the contaminated groundwater and soil-gas. The conclusions drawn from these evaluations are: (1) the system achieved removal efficiencies as high as 99.99 percent for groundwater and 99.9 percent for soil-gas; (2) the effluent groundwater was in compliance with the regulatory discharge requirements of 5 micrograms/L each for TCE and PCE for all test runs; (3) the demonstrated 1,000 gpm system has an estimated capital cost of $4.3 million and annual operating and maintenance cost of approximately $820,000.     

Deactivation of mycotoxins. I. An in vitro study of zearalenone adsorption on new polymeric adsorbents.

This study describes the elimination of zearalenone concentrations in vitro using two new polymeric forms of cross-linked polyvinylpyrrolidone (cryogels of cross-linked PVP). Adsorption of zearalenone was studied under isothermal conditions and simulating pH of intestinal environment. A Freundlich isotherm was used to describe the adsorption data obtained. The results showed significant decrease of zearalenone concentrations, ranging from 33.5-66.2% per 25 mg of polymer. Adsorption capacity (k) was estimated to be higher than that of previously tested adsorbents, including crospovidone. The data indicate the need to investigate structure peculiarities in order to improve mycotoxin deactivation procedures using PVP derivatives.     

Standardization and application of an E.L.S.-bioassay for PCDDs and PCDFs

An early life stage bioassay (E.L.S.-bioassay) for the determination of polychlorinated dibenzo-p-dioxins and dibenzofurans in complex matrices has been developed. The bioassay is based upon mortality, resulting from a typical toxicopathological syndrome in rainbow trout eleutheroembryos. Its reliability is demonstrated by the application to incinerator fly ash. It is concluded, that the E.L.S.-bioassay is a simple, useful and relatively inexpensive method to determine the amount of PCDDs and PCDFs in potentially contaminated environmental samples.     

Overview of the U.S. Environmental Protection Agency's Hazardous Air Pollutant Early Reduction Program.

Under provision of the Clean Air Act Amendments of 1990 Title III, the EPA has proposed a regulation (Early Reduction Program) to allow a six-year compliance extension from Maximum Achievable Control Technology (MACT) standards for sources that voluntarily reduce emissions of Hazardous Air Pollutants (HAPs) by 90 percent or more (95 percent or more for particulates) from a base year of 1987 or later. The emission reduction must be made before the applicable MACT standard is proposed for the source category or be subject to an enforceable commitment to achieve the reduction by January 1, 1994 for sources subject to MACT standards prior to 1994. The primary purpose of this program is to encourage reduction of HAPs emissions sooner than otherwise required. Industry would be allowed additional time in evaluating emission reduction options and developing more cost-effective compliance strategies, although, under strict guidelines to ensure actual, significant and verifiable emission reductions occur.